Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check2 days agoChange DetectedThe page now displays 'México, Mexico, 06700' and uses revision v3.0.2 instead of v3.0.1; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or stock.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated to include new facility names and locations, with a total of 122 locations now listed for the study. Additionally, drug information for dapagliflozin and saxagliptin has been clarified, while some previous location details have been removed.SummaryDifference10%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.